AI assistant
PFIZER INC — Director's Dealing 2022
Feb 25, 2022
29831_dirs_2022-02-25_29896366-4e8a-49cb-bf2d-19d5d7193062.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-02-23
Reporting Person: DAMICO JENNIFER B. (SVP & Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-23 | Common Stock | M | 11748.0000 | $27.3400 | Acquired | 21668.0000 | Direct |
| 2022-02-23 | Common Stock | F | 2339.0000 | $46.8700 | Disposed | 19329.0000 | Direct |
| 2022-02-23 | Common Stock | F | 5815.0000 | $51.2800 | Disposed | 13514.0000 | Direct |
| 2022-02-24 | Common Stock | A | 2893.0000 | $0.0000 | Acquired | 16407.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-23 | Stock Appreciation Rights | $27.3400 | M | 11748.0000 | Disposed | 2022-02-23 | Common Stock (11748.0000) | Direct |
| 2022-02-24 | Stock Appreciation Rights | $45.9600 | A | 11623.0000 | Acquired | 2027-02-24 | Common Stock (11623.0000) | Direct |
| 2022-02-24 | Stock Appreciation Rights | $45.9600 | A | 10222.0000 | Acquired | 2029-02-24 | Common Stock (10222.0000) | Direct |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F6: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F7: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.